Ginkgo Bioworks Holdings (DNA) Current Assets (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Current Assets data on file, last reported at $410.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 27.38% year-over-year to $410.0 million; the trailing twelve-month figure through Mar 2026 stood at $410.0 million (down 27.38% YoY), and the FY2025 full-year result was $471.8 million, down 21.72% from the prior year.
• Current Assets for Q1 2026 stood at $410.0 million, down from $471.8 million in the prior quarter.
• Across five years, Current Assets topped out at $1.7 billion in Q1 2022 and bottomed at $410.0 million in Q1 2026.
• The 5-year median for Current Assets is $903.0 million (2024), against an average of $961.1 million.
• The widest annual swing landed in 2022, when Current Assets surged 165261.75%; it then slumped 41.98% in 2024.
• A 5-year view of Current Assets shows it stood at $1.5 billion in 2022, then slumped by 30.92% to $1.0 billion in 2023, then plunged by 39.83% to $602.7 million in 2024, then retreated by 21.72% to $471.8 million in 2025, then slipped by 13.12% to $410.0 million in 2026.
• The last three Current Assets figures came in at $410.0 million (Q1 2026), $471.8 million (Q4 2025), and $506.1 million (Q3 2025), per Business Quant data.

Peer Comparison